YAN XIJUN,WU NAIFENG,YAN KAIJING,SUN HE,GUO ZHIXIN,ZHU GUOGUANG,LIU WEIWEI,ZHAO LIBIN,LUO RUIZHI
申请号：
NZ60659511
公开号：
NZ606595A
申请日:
2011.08.08
申请国别(地区):
NZ
年份:
2014
代理人:
摘要：
Disclosed is the use of Chinese medicine composition in preparation of a medicament for secondary prevention of coronary heart disease (CHD) in a patient diagnosed as grade II or grade III angina pectoris by the Canadian Cardiovascular Society (CCS)&rsquo； wherein said Chinese medicine composition comprises Radix salvia Miltiorrhiza and Radix Notoginseng extract and Borneol, wherein weight ratio of the Radix salvia Miltiorrhiza and Radix Notoginseng extract to the Borneol is (8-15):1, wherein weight of Salvia Miltiorrhiza and Radix Notoginseng extract is the dry weight, and wherein said Radix Salvia Miltiorrhiza and Radix Notoginseng extract is prepared by extracting Radix Salvia Miltiorrhiza and Radix Notoginseng simultaneously.
